Form 4: LifeStance Health Group CEO Reports Stock Transaction

Sentiment:

Insider Transaction (Form 4)


David Bourdon, Chief Executive Officer and a Director of LifeStance Health Group, Inc., reported multiple transactions in common stock on September 22, 2026.

Summary

  • Bona fide gift: disposed of 150,000 Common Stock on September 22, 2026; holds 1,098,247 after (Direct).
  • Bona fide gift: acquired 150,000 Common Stock on September 22, 2026; holds 150,000 after (Indirect).
  • Bona fide gift: disposed of 150,000 Common Stock on September 22, 2026; holds 948,247 after (Direct).
  • Bona fide gift: acquired 150,000 Common Stock on September 22, 2026; holds 150,000 after (Indirect).

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.

Insider Transactions

David Bourdon — Director, Officer (Chief Executive Officer)

DateTransactionSecuritySharesPriceValueHeld After
2026-09-22Bona fide giftCommon Stock150,000——1,098,247
2026-09-22Bona fide giftCommon Stock150,000——150,000
2026-09-22Bona fide giftCommon Stock150,000——948,247
2026-09-22Bona fide giftCommon Stock150,000——150,000

Key Dates

DateDescription
2026-09-22Bona fide gift (150,000 shares)
2026-09-22Bona fide gift (150,000 shares)
2026-09-22Bona fide gift (150,000 shares)
2026-09-22Bona fide gift (150,000 shares)

Keywords

insider transaction, Form 4, LFST, LifeStance Health Group, Inc., neutral, David Bourdon

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.